Survival benefit-based deceased-donor liver allocation.

Sarcopenia and mortality after liver transplantation. J Am Coll Surg (2010) 2.75

Addressing geographic disparities in liver transplantation through redistricting. Am J Transplant (2013) 2.46

Impact of the hepatopulmonary syndrome MELD exception policy on outcomes of patients after liver transplantation: an analysis of the UNOS database. Gastroenterology (2014) 2.15

Early post-transplant survival: Interaction of MELD score and hospitalization status. J Hepatol (2015) 2.06

Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant Registry. Am J Transplant (2010) 2.04

An examination of liver offers to candidates on the liver transplant wait-list. Gastroenterology (2012) 2.03

Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology (2011) 2.01

Variation in organ quality between liver transplant centers. Am J Transplant (2011) 1.99

Racial and ethnic disparities in access to liver transplantation. Liver Transpl (2010) 1.94

Serum sodium and survival benefit of liver transplantation. Liver Transpl (2015) 1.75

Portal vein thrombosis and liver transplant survival benefit. Liver Transpl (2010) 1.42

Solid-organ transplantation in older adults: current status and future research. Am J Transplant (2012) 1.33

Development of organ-specific donor risk indices. Liver Transpl (2012) 1.26

End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates. Hepatology (2011) 1.19

Liver transplantation: past, present and future. Nat Rev Gastroenterol Hepatol (2013) 1.11

Prioritization for liver transplantation. Nat Rev Gastroenterol Hepatol (2010) 1.05

Contrasting treatment-specific survival using double-robust estimators. Stat Med (2012) 1.04

Donor race does not predict graft failure after liver transplantation. Gastroenterology (2010) 1.03

Impact of the center on graft failure after liver transplantation. Liver Transpl (2013) 0.98

Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list. PLoS One (2013) 0.93

Organ allocation for chronic liver disease: model for end-stage liver disease and beyond. Curr Opin Gastroenterol (2010) 0.92

The evolution in the prioritization for liver transplantation. Ann Gastroenterol (2012) 0.87

Patients With Hepatocellular Carcinoma Have Highest Rates of Wait-listing for Liver Transplantation Among Patients With End-Stage Liver Disease. Clin Gastroenterol Hepatol (2016) 0.87

Pretransplant prediction of posttransplant survival for liver recipients with benign end-stage liver diseases: a nonlinear model. PLoS One (2012) 0.82

Criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation. World J Gastroenterol (2014) 0.82

Management of "very early" hepatocellular carcinoma on cirrhotic patients. World J Hepatol (2014) 0.82

Transplant benefit for patients with hepatocellular carcinoma. World J Gastroenterol (2013) 0.81

Futility and rationing in liver retransplantation: when and how can we say no? J Hepatol (2012) 0.81

Disparities in liver transplantation: the association between donor quality and recipient race/ethnicity and sex. Transplantation (2014) 0.80

Comparison of seven liver allocation models with respect to lives saved among patients on the liver transplant waiting list. Transpl Int (2012) 0.80

Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score. Liver Transpl (2012) 0.79

Liver transplantation in adults: Choosing the appropriate timing. World J Gastrointest Pharmacol Ther (2012) 0.77

Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the Model for End-stage Liver Disease score. J Cachexia Sarcopenia Muscle (2016) 0.77

Association of preoperative parameters with postoperative mortality and long-term survival after liver transplantation. Can J Surg (2011) 0.76

Is liver transplantation using organs donated after cardiac death cost-effective or does it decrease waitlist death by increasing recipient death? HPB (Oxford) (2012) 0.75

Evaluating twenty-years of follow-up after orthotopic liver transplantation, best practice for donor-recipient matching: What can we learn from the past era? World J Transplant (2016) 0.75

Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients. Liver Transpl (2016) 0.75

Living donor liver transplantation for high model for end-stage liver disease score: What have we learned? World J Hepatol (2016) 0.75

Transplantation: Allocation of liver transplants-a road to consensus. Nat Rev Gastroenterol Hepatol (2015) 0.75

Liver transplantation in a patient with complete portal vein thrombosis, is there a surgical way out? A case report. Ann Med Surg (Lond) (2016) 0.75

Decision support for organ offers in liver transplantation. Liver Transpl (2015) 0.75

Liver transplantation: Toward a unified allocation system. Nat Rev Gastroenterol Hepatol (2011) 0.75

Developing a donation after cardiac death risk index for adult and pediatric liver transplantation. World J Transplant (2017) 0.75

Selection of patients with hepatocellular cancer: a difficult balancing between equity, utility, and benefit. Transl Gastroenterol Hepatol (2017) 0.75

A frailty index predicts post-liver transplant morbidity and mortality in HIV-positive patients. AIDS Res Ther (2017) 0.75

Patients' Age Rather Than Model of End-Stage Liver Disease Score Predicts Survival After Liver Transplantation. Dig Dis Sci (2017) 0.75

A model to predict survival in patients with end-stage liver disease. Hepatology (2001) 18.06

Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med (1999) 15.69

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology (2000) 9.74

Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant (2006) 8.03

Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics (2000) 6.19

The survival benefit of liver transplantation. Am J Transplant (2005) 5.08

Development of the new lung allocation system in the United States. Am J Transplant (2006) 4.02

MELD and PELD: application of survival models to liver allocation. Liver Transpl (2001) 3.76

Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol (2001) 2.80

Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology (2007) 2.72

The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant (2008) 2.48

Calculating life years from transplant (LYFT): methods for kidney and kidney-pancreas candidates. Am J Transplant (2008) 2.39

Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology (2002) 2.25

Partly conditional survival models for longitudinal data. Biometrics (2005) 1.94

Re-weighting the model for end-stage liver disease score components. Gastroenterology (2008) 1.83

A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl (2006) 1.73

A sequential stratification method for estimating the effect of a time-dependent experimental treatment in observational studies. Biometrics (2006) 1.63

Simulating the allocation of organs for transplantation. Health Care Manag Sci (2004) 1.31

Mortality experience in recipients undergoing repeat transplantation with expanded criteria donor and non-ECD deceased-donor kidneys. Am J Transplant (2007) 1.09

The analysis of failure times in the presence of competing risks. Biometrics (1978) 11.22

Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant (2006) 8.03

Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med (2000) 4.30

Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J Virol (1998) 4.17

Liver transplantation in the United States, 1999-2008. Am J Transplant (2010) 3.92

Between- and within-cluster covariate effects in the analysis of clustered data. Biometrics (1998) 3.66

Report of a National Conference on Donation after cardiac death. Am J Transplant (2006) 3.04

Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study. Neurology (2008) 2.97

Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr (1998) 2.74

The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant (2008) 2.48

Calculating life years from transplant (LYFT): methods for kidney and kidney-pancreas candidates. Am J Transplant (2008) 2.39

Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology (1984) 2.19

Cyclosporine: five years' experience in cadaveric renal transplantation. N Engl J Med (1984) 2.10

Review article: portal vein obstruction--epidemiology, pathogenesis, natural history, prognosis and treatment. Aliment Pharmacol Ther (2014) 2.05

Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant Registry. Am J Transplant (2010) 2.04

Liver and intestine transplantation in the United States, 1997-2006. Am J Transplant (2008) 2.04

Donation after cardiac death liver transplantation: predictors of outcome. Am J Transplant (2010) 2.02

American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant (2009) 2.00

p53 protein overexpression in low grade dysplasia (LGD) in Barrett's esophagus: immunohistochemical marker predictive of progression. Am J Gastroenterol (2001) 1.91

Methane and nitrous oxide emission from bovine manure management practices in India. Environ Pollut (2006) 1.82

Miami classification for probe-based confocal laser endomicroscopy. Endoscopy (2011) 1.80

Geographic variability in access to primary kidney transplantation in the United States, 1996-2005. Am J Transplant (2007) 1.77

The Ahmed Glaucoma Valve in refractory glaucoma: experiences in Indian eyes. Eye (Lond) (2005) 1.75

First-pass metabolism of cyclosporin by the gut. Lancet (1991) 1.71

Hazard rate models with covariates. Biometrics (1979) 1.69

Recovery and utilization of deceased donor kidneys from small pediatric donors. Am J Transplant (2006) 1.68

Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Health Technol Assess (2010) 1.67

CYP3A gene expression in human gut epithelium. Pharmacogenetics (1994) 1.66

Effects of poststroke pyrexia on stroke outcome : a meta-analysis of studies in patients. Stroke (2000) 1.64

Mechanisms of microbial movement in subsurface materials. Appl Environ Microbiol (1989) 1.64

Geographic differences in event rates by model for end-stage liver disease score. Am J Transplant (2006) 1.62

Selection for and outcome of liver transplantation in alcoholic liver disease. Gastroenterology (1992) 1.62

Neutrophil-free radical generation and enzymatic antioxidants in migraine patients. Cephalalgia (2004) 1.62

A safety device to prevent injury from Kirschner wires. J Hand Surg Eur Vol (2011) 1.58

The riskiest job in medicine: transplant surgeons and organ procurement travel. Am J Transplant (2009) 1.58

Randomized controlled trial of hand-assisted laparoscopic versus open surgical live donor nephrectomy. Transplantation (2001) 1.58

Organ donation and utilization, 1995-2004: entering the collaborative era. Am J Transplant (2006) 1.57

Neutron discrepancies in the DS86 Hiroshima dosimetry system. Health Phys (1992) 1.57

A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantation. Hepatology (1995) 1.56

Long-term follow-up of Barrett's high-grade dysplasia. Am J Gastroenterol (2000) 1.56

Preoperative risk factor assessment in liver transplantation. Surgery (1992) 1.55

Kidney and pancreas transplantation in the United States, 1996-2005. Am J Transplant (2007) 1.55

Breathing circuit obstruction by a foreign body. Anaesth Intensive Care (2004) 1.52

Gold nanoparticles as a contrast agent for in vivo tumor imaging with photoacoustic tomography. Nanotechnology (2009) 1.51

Low-grade dysplasia in Barrett's esophagus - an innocent bystander? Pro. Endoscopy (2007) 1.50

Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients. Antimicrob Agents Chemother (2000) 1.50

Simultaneous liver-kidney transplantation summit: current state and future directions. Am J Transplant (2012) 1.50

Impact of multidetector CT on donor selection and surgical planning before living adult right lobe liver transplantation. AJR Am J Roentgenol (2001) 1.50

MR contrast material for vascular enhancement: value of superparamagnetic iron oxide. AJR Am J Roentgenol (1996) 1.48

Formation of adeno-associated virus circular genomes is differentially regulated by adenovirus E4 ORF6 and E2a gene expression. J Virol (1999) 1.47

Trends in organ donation and transplantation in the United States, 1999-2008. Am J Transplant (2010) 1.47

Clinical value of ACE genotyping in diagnosis of sarcoidosis. Lancet (1997) 1.46

Utilization of kidneys with similar kidney donor risk index values from standard versus expanded criteria donors. Am J Transplant (2012) 1.46

Biological control of mosquito populations through frogs: opportunities & constrains. Indian J Med Res (2008) 1.45

Constituents of Aegle marmelos. Planta Med (1981) 1.44

Effectiveness of mitomycin C in reducing reformation of adhesions following surgery for restrictive strabismus. J Pediatr Ophthalmol Strabismus (2001) 1.43

Ethics, logistics and a trial of transurethral versus open prostatectomy. Br J Urol (1992) 1.39

Impact of modernising medical careers on operative training in otolaryngology. Clin Otolaryngol (2010) 1.38

Access and outcomes among minority transplant patients, 1999-2008, with a focus on determinants of kidney graft survival. Am J Transplant (2010) 1.38

Mesoscale flux-closure domain formation in single-crystal BaTiO3. Nat Commun (2011) 1.38

Study of serum amylase in acute viral hepatitis. J Assoc Physicians India (1993) 1.36

Health-related quality of life in kidney donors from the last five decades: results from the RELIVE study. Am J Transplant (2013) 1.34

Morphine enhances macrophage apoptosis. J Immunol (1998) 1.34

Complications of living donor hepatic lobectomy--a comprehensive report. Am J Transplant (2012) 1.32

What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis. Gut (2004) 1.29

Enteropathogenicity of Plesiomonas shigelloides. J Med Microbiol (1980) 1.27

Esophageal infections in immunosuppressed patients after marrow transplantation. Gastroenterology (1985) 1.26

Kerosene oil poisoning--a childhood menace. Indian Pediatr (1992) 1.26

Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance. Am J Gastroenterol (2000) 1.25

Kidney, pancreas and liver allocation and distribution in the United States. Am J Transplant (2012) 1.24

Spatially different, real-time temporal filtering and dose reduction for dynamic image guidance during neurovascular interventions. Conf Proc IEEE Eng Med Biol Soc (2011) 1.22

Simultaneous liver-kidney transplantation: evaluation to decision making. Am J Transplant (2007) 1.22

Effects of choline deficiency and methotrexate treatment upon liver folate content and distribution. Cancer Res (1991) 1.20

Switchable induced polarization in LaAlO3/SrTiO3 heterostructures. Nano Lett (2012) 1.20

The Causative Classification of Stroke system: an international reliability and optimization study. Neurology (2010) 1.19

Hand-assisted laparoscopic live donor nephrectomy. Urology (1998) 1.19

Marker processes in survival analysis. Lifetime Data Anal (1996) 1.19

Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades. Am J Transplant (2012) 1.19

Trends in organ donation and transplantation in the United States, 1998-2007. Am J Transplant (2009) 1.18

Feasibility of mcroRNAs as biomarkers for Barrett's Esophagus progression: a pilot cross-sectional, phase 2 biomarker study. Am J Gastroenterol (2011) 1.18

Impact of MELD-based allocation on end-stage renal disease after liver transplantation. Am J Transplant (2011) 1.17

Use of fibrin glue in thoracic surgery. Ann Thorac Surg (1985) 1.17

Comparative evaluation of Löwenstein-Jensen proportion method, BacT/ALERT 3D system, and enzymatic pyrazinamidase assay for pyrazinamide susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (2006) 1.16

The risk of bleeding after percutaneous liver biopsy: relation to platelet count. J Clin Gastroenterol (1982) 1.16

Accuracy of volumetric measurements after virtual right hepatectomy in potential donors undergoing living adult liver transplantation. AJR Am J Roentgenol (2001) 1.15

Cavernous hemangioma of the liver: anatomic resection vs. enucleation. Arch Surg (1999) 1.15

ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant (2009) 1.13

Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation. Am J Transplant (2008) 1.13

Observer agreement in the assessment of narrowband imaging system surface patterns in Barrett's esophagus: a multicenter study. Endoscopy (2011) 1.13

Rapid degradation of ferulic acid via 4-vinylguaiacol and vanillin by a newly isolated strain of bacillus coagulans. J Biotechnol (2000) 1.12

Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study. Am J Transplant (2013) 1.11

Epilepsy in India: nuptiality behaviour and fertility. Seizure (2006) 1.10

Dose Reduction Technique Using a Combination of a Region of Interest (ROI) Material X-Ray Attenuator and Spatially Different Temporal Filtering for Fluoroscopic Interventions. Proc SPIE Int Soc Opt Eng (2012) 1.10

Lateral rectus split in the management of Duane's Retraction Syndrome. Ophthalmic Surg Lasers (2001) 1.10